Advances in the Treatment of Hodgkin's Lymphoma

PROGRAM DESCRIPTION This webcast is intended to improve care of patients with Hodgkin’s lymphoma by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at ...

PROGRAM DESCRIPTION
This webcast is intended to improve care of patients with Hodgkin’s lymphoma by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.

EDUCATIONAL OBJECTIVES
As a result of participating in the activity, learners should be better able to: Evaluate the efficacy and safety of nivolumab and pembrolizumab in patients with relapsed/refractory classic Hodgkin’s lymphoma (HL)Assess the efficacy and safety of PD-1 and PD-L1 blockade in combination with brentuximab vedotin and autologous stem cell and allogenic stem cell transplantation in patients with HL

---

Write the first review

Resource tags